‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...
FierceBiotech13d
GSK inks 2nd neuro pact in weeks, this time with Danish biotech Muna in Alzheimer's
GSK has penned another neuroscience pact, this time with Danish biotech Muna Therapeutics. | GSK has penned another ...
FiercePharma11d
Fierce Pharma Asia—Sanofi's $1B manufacturing base; GSK's ADC deal, Shingrix recalibration in China
Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...
Yahoo Finance13d
GSK taps a startup for shot at Alzheimer’s drug
Once the companies are satisfied with the target, GSK will be in charge of taking the programs forward. It will lead drug ...
GlobalData on MSN1d
GSK’s lung cancer therapy gains EMA PRIME designation
GSK’s GSK’227 has gained Priority Medicines (PRIME) designation from the EMA for the treatment of relapsed ES-SCLC.
BioSpace7d
Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More
GSK, Gilead and Arcellx, Vertex and more present new data at the American Society of Hematology annual meeting just as sickle cell therapies Casgevy and Lyfgenia have a new outcomes-based payment ...
biopharma-reporter7d
GSK and Muna Therapeutics partner to develop new treatments for Alzheimer’s
The partnership revolves around Muna Therapeutics’ technology platform, which employs a spatial multi-omics approach to ...
FiercePharma8d
ASH: With survival win against J&J's Darzalex, GSK bolsters case for return of myeloma ADC Blenrep
GSK is now looking to start a phase 3 trial in the first-line setting shortly, Abdullah said. The DREAMM-10 study will once again pit Blenrep against Darzalex, this time as part of front-line ...